Rosa A van Amerongen

Next-generation sequencing in NSCLC and melanoma patients: a cost and budget impact analysis

W. V. van Harten, P. Nederlof, M. Vogel, 2016, Ecancermedicalscience.

WT1-specific TCRs directed against newly identified peptides install antitumor reactivity against acute myeloid leukemia and ovarian carcinoma

R. Hagedoorn, M. Heemskerk, M. Griffioen, 2022, Journal for ImmunoTherapy of Cancer.

Human iPSC-derived preclinical models to identify toxicity of tumor-specific T cells with clinical potential

R. Hagedoorn, M. Heemskerk, C. Freund, 2023, Molecular therapy. Methods & clinical development.

Exosomes derived from mesenchymal non‐small cell lung cancer cells promote chemoresistance

A. Möller, A. Wiegmans, S. Ham, 2017, International journal of cancer.

PRAME and CTCFL-reactive TCRs for the treatment of ovarian cancer

R. Hagedoorn, J. Falkenburg, M. Heemskerk, 2023, Frontiers in Immunology.